Cross-Faculty Seminar Series: An introduction to Scientia Clinical Research and phase I trials

An introduction to Scientia Clinical Research and phase I trials
Dr Charlotte Lemech
Scientia Clinical Research, UNSW
Date & Time: Wednesday 12 April at 4pm followed by Happy Hour
Abstract: This seminar will provide an introduction to Scientia Clinical Research, a dedicated clinical trial facility at Prince of Wales Hospital.  This unit will focus on phase 1 first-in-human and first-in-patient studies in oncology, haematology and other disciplines as well as support later phase studies across therapeutic disciplines.  Details of phase 1 trial design and transition from preclinical to clinical studies will be discussed.
Biography: Dr Charlotte Lemech is a medical oncologist and the medical director of Scientia Clinical Research, a dedicated clinical trials facility at Prince of Wales Hospital.
She graduated from the University of New South Wales and was awarded her fellowship in Medical Oncology by the Royal Australasian College of Physicians in 2012.
She then completed a 4-year fellowship in London at a dedicated clinical trials facility, Sarah Cannon Research Institute UK.  Here, she gained expertise in both phase I and later-phase clinical trials across a spectrum of tumour streams and molecular targets, including immunotherapy.  She also worked as part of the multidisciplinary team in genitourinary and breast cancers at University College London (UCL) Hospital.  At the same time, she completed a clinical and laboratory based MD(res) at the UCL Cancer Institute with the study of biomarker development in endometrial cancer including circulating tumour cells and methylation studies.  
She returned to Australia in 2015 and became the inaugural medical director of Scientia Clinical Research (SCR), co-located with the Nelune Comprehensive Cancer Centre at Prince of Wales Hospital.